Australia's most trusted
source of pharma news
Tuesday, 20 January 2026
Posted 16 January 2025 AM
AbbVie is relocating its Australian headquarters to the Sydney CBD at the end of this year, bringing the company's Therapeutics and Aesthetics teams under the one roof for the first time.
The new address is 321 Kent Street, a 21-storey tower in the heart of the CBD, known for its glass facade and large forecourt, views of Darling Harbour and natural light.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.